// App-Quantinova.ai

OP015 : Biomarker correlation with endoscopic outcomes in patients with Crohn’s disease: data from CALM

Researchers

Presenter

  • W Reinisch

Principal Investigators

  • R Panaccione

  • P Bossuyt

  • F Baert

  • A Armuzzi

  • S Travis

  • S Danese

  • W J Sandborn

  • G D'Haens

  • S Berg

  • J -F Maa

  • J Petersson

  • E Neimark

  • A M Robinson

  • J -F Colombel

Medical Centers

  • Medical University of Vienna, Vienna, Austria

  • Imelda Hospital, Bonheiden, Belgium

  • AZ Delta Roeselare-Menen, Menen, Belgium

  • Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica, Rome, Italy

  • Oxford University Hospital, Oxford,

  • Istituto Clinico Humanitas, Milan, Italy

  • University of California, San Diego, La Jolla, CA

  • Academic Medical Center, Amsterdam, Netherlands

  • AbbVie AB, Solna, Sweden

  • AbbVie, Inc., North Chicago, IL

  • Icahn School of Medicine at Mount Sinai, New York, NY

Locations

  • Austria

  • Canada

  • Belgium

  • Italy

  • United Kingdom

  • United States

  • Netherlands

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Phosphatidylinositol-binding clathrin assembly protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved